Teplizumab Biosimilar, Human CD3e Monoclonal Antibody
$200.00 – $1,200.00
The research grade Teplizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
- Details & Specifications
- References
- More Offers
| Catalog No. | C056P |
|---|---|
| Product Name | Teplizumab Biosimilar, Human CD3e Monoclonal Antibody |
| Supplier Name | Syd Labs, Inc. |
| Brand Name | Syd Labs |
| Synonyms | cluster of differentiation 3, CD3D, CD3E, CD3G |
| Summary | Recombinant human IgG1 Monoclonal Antibody. Muromonab is the parental mouse anti-CD3 mAb (OKT3 or OKT-3); teplizumab is the humanized version with the human IgG1 kappa constant regions and the Fc region having Fc receptor non-binding (FNB) properties. |
| Clone | OKT3 or OKT-3. |
| Isotype | Human IgG1 kappa. |
| Source/Host | The anti-human CD3 monoclonal antibody teplizumab biosimilar was produced in mammalian cells. |
| Specificity/Sensitivity | The in vivo grade teplizumab biosimilar specifically binds to the human T cell receptor CD3. |
| Form Of Antibody | 0.2 uM filtered solution, pH 7.4, no stabilizers or preservatives. |
| Endotoxin | <1 EU/mg of the protein by the LAL method. |
| Purity | >95% by SDS-PAGE under reducing conditions and HPLC. |
| Shipping | The monoclonal antibody ibalizumab is shipped with ice pack. Upon receipt, store it immediately at the temperature recommended below. |
| Stability & Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied. |
| Note | The research grade Teplizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator. |
| Order Offline | Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card. |
Description
C056P: Teplizumab Biosimilar, CD3 Monoclonal Antibody
The anti-human CD3 monoclonal antibody teplizumab biosimilar was produced in mammalian cells.
Background of Teplizumab Biosimilar
Teplizumab biosimilar uses the same protein sequences as the therapeutic antibody teplizumab (humanized OKT3).
A fully human monoclonal antibody that binds to CD3 epsilon of the T cell receptor-CD3 complex, teplizumab (humanized OKT-3) is used to delay the onset of stage 3 type 1 diabetes (T1D) in people with stage 2 T1D.
Syd Labs provides the following anti-human CD3 antibodies:
Muromonab biosimilar, research grade, anti-human CD3 monoclonal antibody (Clone: OKT3)
Teplizumab biosimilar, research grade, anti-human CD3 monoclonal antibody (Clone: OKT3)
Foralumab biosimilar, research grade, anti-human CD3 monoclonal antibody (Clone: OKT3)
Anti-human CD3 monoclonal antibody (Clone: OKT3)
Anti-human CD3 monoclonal antibody (Clone: SP34-2)
Anti-human CD3 monoclonal antibody (Clone: UCHT1)
Syd Labs provides the following anti-mouse CD3 antibodies:
Anti-mouse CD3e monoclonal antibody (Clone: 145-2C11)
Anti-mouse CD3e monoclonal antibody (Clone: 500A2)
Anti-mouse CD3 monoclonal antibody (Clone: 17A2)
Please remember our product information: Teplizumab Biosimilar, CD3 Monoclonal Antibody: C056P Syd Labs
